✦ LIBER ✦

Introduction: rationale for using drotrecogin alfa (activated) in patients with severe sepsis

✍ Scribed by Jean-François Dhainaut

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Selecting patients with severe sepsis fo

✍ Jean-Pierre Sollet; Gary E Garber 📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 125 KB

Use of Drotrecogin alfa (activated) in O

✍ Dr. Sherri L. Alexander; Dr. Frank R. Ernst 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 179 KB

Management of patients with severe sepsi

✍ Pierre-François Laterre; Darell Heiselman 📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 223 KB

Pharmacokinetic-pharmacodynamic analysis

✍ MACIAS, W; DHAINAUT, J; YAN, S; HELTERBRAND, J; SEGER, M; JOHNSONIII, G; SMALL, 📂 Article 📅 2002 🏛 Nature Publishing Group 🌐 English ⚖ 140 KB

Pharmacokinetics and Clinical Use of Dro

✍ Dr. Keith M. Olsen; Dr. Steven J. Martin 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 72 KB

Predictors of Hospital Mortality for Pat

✍ Dr. Scott T. Micek; Dr. Warren Isakow; Dr. William Shannon; Dr. Marin H. Kollef 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 90 KB